Results
1
High return on equity, past performance and sound balance sheet.
1 companies
Genmab
Market Cap: DKK 120.6b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,958.00
7D
-3.2%
1Y
41.4%